Loading...
935106861
info@markelab.com
Precio
387.5€ (100 µg)
Zalifrelimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CTLA4/CD152, Balstilimab monotherapy and combined with zalifrelimab in the treatment of metastatic cervical cancer.
Biosimilars
Human
Monoclonal
Human
CTLA4/CD152
Human
IgG1 Kappa
Unconjugated
Liquid
ELISA, WB
100 µg
1 mg
Recombinant
> 95%
Purified from cell culture supernatants by Protein A/G chromatography.
0.01 M PBS. pH 7.4.
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
No
Shipped within 7-12 working days.
Biosimilars
CAS Number 2148321-69-9
Precio a consultar
Ver másPrecio a consultar
Ver másPrecio a consultar
Ver más